Imaging Axillary Node Status in Breast Cancer Patients
Author Information
Author(s): Al-Yasi A R, Carroll M J, Ellison D, Granowska M, Mather S J, Wells C A, Carpenter R, Britton K E
Primary Institution: St Bartholomew's Hospital, London, UK
Hypothesis
Can Tc-99m radiolabelled anti-PEM monoclonal antibody imaging accurately identify axillary node status prior to surgery in breast cancer patients?
Conclusion
The study demonstrates that Tc-99m hHMFG1 imaging can effectively identify axillary node involvement in breast cancer patients before surgery.
Supporting Evidence
- 93% specificity and 92% positive predictive value were achieved in identifying axillary node involvement.
- Change detection analysis improved the accuracy of imaging compared to conventional methods.
- Imaging was performed within two weeks before surgery, allowing timely surgical planning.
Takeaway
Doctors can use a special imaging technique to see if there are cancerous nodes in the armpit of breast cancer patients before surgery, which helps them decide what surgery is needed.
Methodology
The study used Tc-99m radiolabelled hHMFG1 monoclonal antibody imaging and change detection analysis to assess axillary node status in patients prior to surgery.
Potential Biases
Potential bias due to the reliance on imaging results which may not detect micrometastases.
Limitations
The sensitivity of the imaging technique was only 61%, leading to some false negatives.
Participant Demographics
Patients aged 40-80 years, mean age 57.3 years, with breast tumors ranging from 10-50 mm in diameter.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website